ArticleThe Journal of clinical investigation2000

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

M Febbraio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.